VCs Warming To Diagnostics As Personalized Medicine Appears On Horizon
This article was originally published in The Gray Sheet
Executive Summary
Diagnostic firms are gaining favor in venture capitalist circles as healthcare moves toward targeted medicine, according to BioAdvance Ventures Managing Director Gary Kurtzman, MD
You may also be interested in...
Payors Will Help Diagnostics Eclipse Drugs In New Medicine Age – Investor
Medical diagnostics' profitability will supersede that of drugs in an age of personalized medicine, with the payor community driving the change, predicted Steven Burrill, CEO of venture capital and merchant banking firm Burrill & Company
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.